EMAIL THIS PAGE TO A FRIEND

American journal of physiology. Regulatory, integrative and comparative physiology

Type 1 cannabinoid receptor modulates water deprivation-induced homeostatic responses.


PMID 26468265

Abstract

The present study investigated the type 1 cannabinoid receptor (CB1R) as a potential candidate to mediate the homeostatic responses triggered by 24 h of water deprivation, which constitutes primarily a hydroelectrolytic challenge and also significantly impacts energy homeostasis. The present results demonstrated for the first time that CB1R mRNA expression is increased in the hypothalamus of water-deprived (WD) rats. Furthermore, the administration of ACEA, a CB1R selective agonist, potentiated WD-induced dipsogenic effect, whereas AM251, a CB1R antagonist, attenuated not only water but also salt intake in response to WD. In parallel with the modulation of thirst and salt appetite, we confirmed that CB1Rs are essential for the development of appropriated neuroendocrine responses. Although the administration of ACEA or AM251 did not produce any effects on WD-induced arginine vasopressin (AVP) secretion, oxytocin (OXT) plasma concentrations were significantly decreased in WD rats treated with ACEA. At the genomic level, ACEA significantly decreased AVP and OXT mRNA expression in the hypothalamus of WD rats, whereas AM251 potentiated both basal and WD-induced stimulatory effects on the transcription of AVP and OXT genes. In addition, we showed that water deprivation alone upregulated proopiomelanocortin, Agouti-related peptide, melanin-concentrating hormone, and orexin A mRNA levels in the hypothalamus, and that CB1Rs regulate main central peptidergic pathways controlling food intake, being that most of these effects were also significantly influenced by the hydration status. In conclusion, the present study demonstrated that CB1Rs participate in the homeostatic responses regulating fluid balance and energy homeostasis during water deprivation.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB2500190
Anti-Cannabinoid receptor 1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
C1108 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
C2866 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
C1233 Anti-Cannabinoid Receptor 1 antibody produced in rabbit, affinity isolated antibody, buffered aqueous glycerol solution
SAB1305934
ANTI-CB1 (CENTER) antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
SAB2502004
Anti-CNR1 (N-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2502003
Anti-CNR1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1405638
Anti-CNR1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
SAB4500345
Anti-CNR1 antibody produced in rabbit, affinity isolated antibody
SAB2501950
Anti-OXT (C-terminal) antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2106566
Anti-OXT antibody produced in rabbit, affinity isolated antibody
A9719
Arachidonyl-2′-chloroethylamide hydrate, ≥97% (HPLC), oil
C22H36ClNO · xH2O
V9879
[Arg8]-Vasopressin acetate salt, ≥95% (HPLC)
C46H65N15O12S2 · xC2H4O2
WH0001268M1
Monoclonal Anti-CNR1 antibody produced in mouse, clone 2F9, purified immunoglobulin, buffered aqueous solution
SAB1403683
Monoclonal Anti-CNR1, (N-terminal) antibody produced in mouse, clone 1F9, purified immunoglobulin, buffered aqueous solution